Found 5 matching trials
Pelacarsen Roll-over Extension Program
PHASE3This non-randomized, rollover extension study will provide post-trial acces...
Location
Parkway Medical Center
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
PHASE3This open-label extension study will provide post-trial access to pelacarse...
Location
SEC Clinical Research LLC
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
PHASE2The purpose of this study is to evaluate the efficacy, safety and tolerabil...
Location
Heart Center Research Llc
Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD
PHASE3Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase...
Location
Parkway Medical Center
An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
PHASE3This non-randomized, open-label extension study will provide post-trial acc...
Status
Active Not Recruiting
Location
Novartis Investigative Site